|
by Anthony Roberts - Viagra (Sildenafil citrate)
is a drug used to treat erectile dysfunction (impotence)
in males and pulmonary arterial hypertension (PAH).
Background
The pharmaceutical company, Pfizer, originally
developed Viagra. In 1006, the FDA approved Viagra
as the first drug patented for use of erectile dysfunction
in the United States. They are blue, diamond-shaped
pills with "Pfizer" marked on one side and "VGR
XX." The XX is the dosage, which is either 25,50,
or 100 mgs. Viagra is also sold under the
brand name Revatio and generically under various
other names. It is also widely availabe by
many research companies and underground labs.
Action
Viagra treats erectile dys function and works
by relaxing muscles and increases blood flow to
particular areas of the body (in this case, the
penis, specifically). Its effects last up
to four hours. The most common side effects
of Viagra are headache, facial flushing, and upset
stomach. Rarely, blurred vision, or sensitivity
to light may briefly occur.
As well as treating impotence, Sildenafil Citrate
can also be effective in treating Pulmonary Arterial
Hypertension (PAH). Similarly to how it acts
to relax muscles of the penis, it relaxes arterial
walls; therefore, reducing resistance and pressure
in the arteries.
Sildenafil Citrate is solely active in relaxing
muscles and increasing blood flow to the heart,
lungs and penis due to PDE-5, yet vasodilation is
not increased in other parts of the body.
Technical Data
In studies where Viagra was administered to over
3700 patients, 19-87 years old in world wide clinical
trials. More than 550 patients received treatment
post 1 year. 2.5% of the Viagra subjects and
2.3% of the placebo subjects reported adverse effects,
which were all considered mild. These reported
side effects included abnormal or blurred vision
and increased sensitivity to light (1). All
other negative reactions reported, including URI,
flu symptoms, back pain and arthralgia, occurred
at a rate of less than 2% and equally common in
the placebo and Viagra administered groups (1).
Effects worsened and were reported more frequently
as dosages increased (1).
Other studies measured duration of sexually stimulated
erection using a Rigiscan device. Duration
of rigidity was increased by 60% with Viagra use
(2).
In 16 separate 4-24 week trials of men (over
18 years old) who suffered from impotence for longer
than 6 months, dosages between 10-200 mgs were administered
(3). Significant improvements in erectile
function, including frequency of penetration as
well as erection duration post penetration, were
reported with Sildenfil treatment compared to the
placebo group (4). Erections were improved in 72%
of the Viagra group verses 18% of the placebo group
(5). In all cases effects were dependant upon
dosage and improvement was the greatest when dosage
exceeded 100 mgs (6). Responses were decreased
by 40-60% in patients suffering from diabetes and
prostatectomy, respectively (7)(8). Withdrawal
rates were less than 5% related to negative side
effects and limited response rates (9).
Sildenafil citrate is
the chemical name of active ingredient in Viagra.
Viagra is a registered trademark of Pfizer
Inc. in the United States and/or other countries.
Viagra Resources
Viagra Prescribing
Information
|

|
| Trivial Name |
Viagra (Sildenafil citrate) |
| Systematic Name |
1-[4-ethoxy-3-(6,7-dihydro-1-methyl-
7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)
phenylsulfonyl]-4-methylpiperazine citrate |
| CAS Number |
171599-83-0 |
| ATC Code |
G04BE03 |
| Merck Index Number |
123789 |
| Chemical Formula |
22H30N6O4S |
| Molecular Weight |
474.6 g/mol |
| Bioavailability |
40-41% |
| Metabolism |
Hepatic |
| Elimination Half Life |
3-4 hours |
| Excretion |
CYP3A4 |
| Legal Status |
Rx only/POM |
| Route of Administration |
Oral |
References
- http://www.rxlist.com/cgi/generic/viagra_ad.htm,
2007, 28, February
- FDA Centre for Drug Evaluation and Research.
Joint clinical review for NDA-20-895. January
1998.
- Boolell M et al. Sildenafil, a novel effective
oral therapy for male erectile dysfunction.
Br.J.Urol. 1996; 37: 257-261.
- Goldstein I et al for the Sildenafil Study
Group. Oral sildenafil in the treatment of erectile
dysfunction. N.Engl.J.Med 1998; 338: 1397-1404.
- Rendell MS, Rajfer J, Wicker PA et al. Sildenafil
for Treatment of Erectile Dysfunction in Men
With Diabetes. A Randomized Controlled Trial.
JAMA 1999; 281: 421-426
- FDA Centre for Drug Evaluation and Research.
Joint clinical review for NDA-20-895. January
1998.
- Rendell MS, Rajfer J, Wicker PA et al. Sildenafil
for Treatment of Erectile Dysfunction in Men
With Diabetes. A Randomized Controlled Trial.
JAMA 1999; 281: 421-426
- FDA Centre for Drug Evaluation and Research.
Joint clinical review for NDA-20-895. January
1998.
- Morales A et al. Clinical safety of oral
sildenafil citrate (Viagra) in the treatment
of erectile dysfunction. Int.J.Impot.Res. 1998;
10: 69-74.
Bodybuilding eBooks
Beyond Steroids by Anthony Roberts - The Newest and Most Effective Bodybuilding
Drugs
Burn the
Fat, Feed the Muscle by Tom Venuto - Secrets of the World's Best Bodybuilders
& Fitness Models
Chemical Muscle Enhancement by Author L Rea - Bodybuilder's Desk Reference
Chemical Wizardry by George Spellwin - The Definitive Anabolic Steroid and
Physique Enhancement Database
The Layman's Guide
to Steroids - Mick Hart's Anabolic Steroid Guides
Muscle Building Nutrition by Will Brink - Serious Lean Muscle Gains without
the Bodyfat
|